7:00 am

REGISTRATION & NETWORKING BREAKFAST

 

7:30 am

LONGWOOD FUND INTRODUCTION

Christoph Westphal, General Partner, Longwood Fund

​

8:00 am

BIG BIOPHARMA PIPELINE SOURCING

Joachim Fruebis, Corporate VP, Head, Cell Therapy R&D, Novo Nordisk

Shiva Malek, Global Head, Oncology, Novartis

Iskra Reic, EVP, Vaccines & Immune Therapies, AstraZeneca

Moderator: Cody Powers, Principal, ZS Associates

 

8:30 am

CROSS-BORDER COLLABORATION

Ed Hu, Vice Chair & Global CIO, WuXi

Richard Paulson, CEO, Karyopharm

Nikolay Savchuk, Chair, Viriom Inc

Bill Watt, President, Astellas Venture Management

Moderator: James Sapirstein, CEO, First Wave BioPharma

 

9:00 am

FIRESIDE CHAT: SPOTLIGHT ON STANFORD INNOVATION

Lloyd Minor, Dean, Stanford School of Medicine

Sylvia Plevritis, Chair, Department of Biomedical Data Science, Stanford University 

Marc Tessier-Lavigne, former President, Stanford University

Irv Weissman,  Ludwig Professor, Clinical Investigation in Cancer Research, Stanford University

Moderator: Christoph Westphal, General Partner, Longwood Fund

 

9:25 am

ENSURING HEALTH EQUITY AND ACCESS

Aida Habtezion, CMO, Head, WW Medical & Safety, Pfizer

Steve Hahn, CEO, Harbinger Health; former Commissioner, FDA

Sabrina Johnson, CEO, Daré Bioscience

Cindy Perettie, EVP, Kite, a Gilead Company

Moderator: Ariel Katz, CEO, H1

​

9:55 am

NETWORKING BREAK

 

10:20 am

R&D COLLABORATION

Nenad Grmusa, CEO, DEM BioPharma

Sek Kathiresan, CEO, Verve Therapeutics

Johan Luthman, EVP, R&D, Lundbeck

Ryan Richardson¸ Chief Strategy Officer, BioNTech

Moderator: Zhen Su, CEO, Marengo Therapeutics

 

10:50 am

ACCELERATING DRUG DEVELOPMENT

Judy Chou, CEO, AltruBio

Fabrice Chouraqui, CEO, Cellarity

Larry Hamann, CEO, Interdict Bio

Carl Hansen, CEO, Abcellera

Moderator: Jim Anthony, President, Parexel Biotech

 

11:20 am

RECRUITING AND RETAINING TALENT

Ram Aiyar¸ CEO, Korro Bio

Quita Highsmith, Chief Diversity Officer, Genentech

Catherine Sohn, Board Director, Jazz Pharmaceuticals 

Alex Zhavoronkov, CEO, Insilco Medicine

Moderator: Sandra Glucksmann, CEO, Sensorium Therapeutics

​

11:50 am

FIRESIDE CHAT: FROM PHARMA TO BIOTECH CEO

Marianne De Backer, CEO, Vir Biotechnology

Henry Gosebruch, CEO, Neumora

Mathai Mammen, CEO, FogPharma

Moderator: John Flavin, CEO, Portal Innovations

​

12:10 pm

NETWORKING LUNCHEON

 

1:00 pm

RARE DISEASE INNOVATION

Nasha Fitter, CEO, FOXG1 Research

Ioannis Sapountzis, Corporate SVP & Global Head, Therapeutic Areas, Boehringer Ingelheim

Shalini Sharp, former CFO, Ultragenyx 

Jason Yaffe, Assoc Partner, Global Rare Disease Lead, ZS

Moderator: Brinda Balakrishnan, CBDO, Biomarin

 

1:30 pm

GETTING TO REGULATORY APPROVAL

Sandi Dunn, CEO, Phoenix Molecular Designs

Marshall Fordyce, CEO, Vera Therapeutics

Orr Inbar, CEO, QuantHealth

Thomas Lonngren, Chair, Egetis; former Executive Director, EMA

Moderator: Pascal Touchon, CEO, Atara

 

2:00 pm

DEAL-MAKING LANDSCAPE

Philippe Lopes-Fernandes, CBO, Ipsen

George Magrath, CEO, Ocuphire Pharma

George Montgomery, CFO, Neuvogen

Dan Paterson, CEO, Verastem Oncology

Moderator: Mark McKenna, former CEO, Prometheus Biosciences

​

2:30 pm

INNOVATIVE COMMERCIAL MODELS

Chris Benecchi, CBO, Sage Therapeutics

Teresa Bitetti, President, Global Oncology, Takeda

Arpa Garay, former CCO, Moderna

Kabir Nath, CEO, COMPASS Pathways

Moderator: Stephen Blaising, Co-Founder & Chair, Brain Surgery Worldwide, Inc.

 

3:00 pm

NETWORKING BREAK

 

3:30 pm

REGULATORY & INDUSTRY ROUNDTABLE

Peter Marks, Director, CBER, FDA

Steve Hahn, former Commissioner, FDA

Moderator: Christoph Westphal, General Partner, Longwood Fund

 

4:00 pm

THE FUTURE OF GENETIC THERAPIES

Michael Amoroso, CEO, Precision BioSciences

Jason Cole, CEO, SalioGen
Gilmore O’Neill, CEO, Editas Medicine

Morten Sogaard, President, Astellas GT Research & Tech Ops, Astellas

Moderator: Alex Harding, Head, BD, CRISPR Therapeutics

​

4:30 pm

STRENGTH IN THE SYNDICATE

Vik Bajaj, Managing Director, Foresite Capital

Alaa Halawa, Executive Director, Mubadala

Ittai Harel, Managing Partner, Healthtech, Pitango

Rachel Mears, Partner, Jeito Capital

Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund

 

5:00 – 7:00 pm

COCKTAIL RECEPTION